Bionpharma Atovaquone Oral Suspension - recalled due to Cohnella bacteria, United States
2 weeks ago •source fda.gov • details
Recall notice
3 years ago • business
Regulatory Report
N6141 Industrial Park Drive, Munising, 49862 Michigan, United States
' - Employees have experienced symptoms of shortness of breath, fatigue, frequent headache, and dizziness since the mandated wearing of a face covering. It is believed the wearing of a face covering creates an oxygen deficiency which is responsible for the symptoms when engaged in any type of activity. - The literature indicates impaired thinking or coordination can occur in an oxygen-deficient environment. Impaired thinking is not suitable in a prison where employees must always be alert. A momentary loss of coordination or impaired thinking could be devastating when performing a potentially dangerous activity, such as climbing a ladder.2 weeks ago •source fda.gov • details
Recall notice
3 weeks ago •reported by user-ngwnh548 • details
2 days ago •reported by user-crxw8265 • details
3 weeks ago •reported by user-tcqh4699 • details
2 weeks ago •reported by user-zjdvb238 • details
2 weeks ago •reported by user-tmnqm616 • details
1 week ago •reported by user-hzgc4123 • details
2 days ago •reported by user-jbth1992 • details
2 weeks ago •reported by user-rvzw7298 • details
6 days ago •reported by user-ppxph641 • details
Search